Author: Healio ophthalmology

Keynote lecture focuses on latest outcomes, new developments of corneal regeneration

ATHENS, Greece — One of the keynote lectures during Cornea Day at the European Society of Cataract and Refractive Surgeons winter meeting focused on corneal regeneration, from limbal stem cell transplantation to the latest tissue engineering approaches for ocular surface reconstruction. Since the first paper on the topic was published in 1997, several protocols for limbal stem cell culture and transplantation were developed.

New laser performs precise capsulotomies, costs less than femtosecond laser

ATHENS, Greece — A new compact laser has the ability to perform precise, perfectly round capsulotomies at a fraction of the cost of a femtosecond laser, according to one speaker here.“An additional advantage is that the laser changes the collagen phase, and capsulotomies are highly resistant to tear, highly elastic and extensible,” Pavel Stodulka, MD, said at the European Society of Cataract and Refractive Surgeons winter meeting.

Fyodorov Lecture focuses on latest advances in keratoconus management

ATHENS, Greece — Modern approaches to keratoconus management were the topic of this year’s Fyodorov Lecture, awarded at the European Society of Cataract and Refractive Surgeons winter meeting to José L. Güell, MD, PhD. Two strategies, he said, have been validated by a long positive experience and studies: corneal cross-linking (CXL) and keratoplasty.

ForeseeHome AMD monitoring program available for Medicare patients in US

The ForeseeHome AMD monitoring program is available by prescription for eligible Medicare patients in the U.S. who have dry age-related macular degeneration and are at risk for developing wet AMD, Notal Vision announced in a press release. “Notal Vision is extremely pleased to achieve this significant milestone with the ForeseeHome AMD monitoring system. We have worked diligently for almost 2 years with the goal of ensuring this device is available to eligible patients enrolled in Medicare,” Barak Azmon, MD, CEO of Notal Vision, said in the release.

High rate of severe, potentially blinding complications reported with cosmetic iris implants

ATHENS, Greece — Cosmetic iris implants are a non-approved, high-risk procedure that can lead to severe, potentially blinding complications in the majority of cases, a speaker said at the European Society of Cataract and Refractive Surgeons winter meeting. Wajiha Kheir, MD, told the audience that 700 procedures were performed with the NewIris implant (Kahn Medical Devices) since 2010 and that many complications have been reported, including increased IOP, iritis with keratic precipitates, corneal edema and hyphema. Use of the implant was discontinued because of irreversible ocular damage.

ESCRS, HSIOIRS presidents welcome meeting attendees in Athens

ATHENS, Greece — In welcoming the audience of the 20th European Society of Cataract and Refractive Surgeons winter meeting, ESCRS president David Spalton, MD, said he was honored and delighted to do so in the city that gave birth to modern medicine 2,500 years ago.“It is amazing to look out of my bedroom’s window, see the Acropolis and think that there is where everything started. In the golden age of Pericles, Hippocrates established the basic principles and ethics of modern medicine. His ‘do no harm’ is still underlying our medical (Read more...)

Presenter: Minimizing disparity between intraocular, intracranial pressures can prevent glaucoma

ATLANTA – In a special session here at SECO, John Berdahl, MD, theorized that glaucoma results when the difference between the cerebrospinal fluid and intraocular pressures is too great.Berdahl said he evaluated 50,000 patients who had lumbar puncture over the course of 20 years and found that intracranial pressure (ICP), or cerebrospinal fluid (CSF) pressure, was lower in people who had glaucoma and higher in people with ocular hypertension.

VIDEO: Surgeon presents positive study results of Mydrane ophthalmic solution

ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons winter meeting, Béatrice Cochener, MD, PhD, presents results from a study of Mydrane (tropicamide 0.02%, phenylephrine 0.31%, lidocaine 1%, Théa) as a fixed dose given intracamerally before cataract surgery. The study found that the combination of mydriatic and anesthetic provided fast pupil dilation and extra comfort for the patient while avoiding toxic effects of drops on the ocular surface.

Técnica de bolsa é similar ao túnel para o implante de segmentos de anel corneano intraestromal

Até cerca de 15 anos atrás, os pacientes com ceratocone tinham poucas opções de tratamento disponíveis para eles: lentes de contato permeáveis a gases, em uma ponta do espectro de tratamento, e a ceratoplastia penetrante, na outra. Felizmente, hoje temos acesso a uma infinidade de tratamentos, incluindo a interligação de colágeno da córnea e a PRK orientada pela topografia.Um dos tratamentos mais interessantes para o ceratocone é a utilização de segmentos de anel corneano intraestromal (ICRS), os quais ajudam a reduzir os erros de refração, melhoram a acuidade visual e (Read more...)

La técnica de bolsillo es similar a la de túnel para el implante de segmentos de anillo corneal intrastromal

Hasta hace unos 15 años, los pacientes con queratocono tenían pocas opciones de tratamiento disponibles, es decir, lentes de contacto permeables al gas en un extremo del espectro del tratamiento y la queratoplastia penetrante en el otro. Afortunadamente, ahora tenemos acceso a innumerables tratamientos, como el entrecruzamiento del colágeno corneal y PRK guiado por topografía.Uno de los tratamientos de queratocono más interesantes es el uso de segmentos de anillos corneales intrasomales (ICRS), que ayudan a reducir los errores refractivos, mejorar la agudeza visual y regularizar la superficie de la córnea. (Read more...)

Second Sight announces new distribution agreement

Second Sight Medical Products announced an exclusive agreement with Tecnosalud for the company to distribute its Argus II Retinal Prosthesis System in Argentina, according to a press release.Tecnosalud will be responsible for in-county sales, marketing, national reimbursement and surgical and technical support of the product. This distribution agreement is part of Second Sight’s plans to expand into South America.